nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP3A4—Everolimus—kidney cancer	0.0497	0.189	CbGbCtD
Sevoflurane—ALB—Erlotinib—kidney cancer	0.0401	0.152	CbGbCtD
Sevoflurane—CYP3A4—Temsirolimus—kidney cancer	0.0336	0.127	CbGbCtD
Sevoflurane—CYP2B6—Sorafenib—kidney cancer	0.0333	0.126	CbGbCtD
Sevoflurane—CYP2B6—Doxorubicin—kidney cancer	0.0202	0.0767	CbGbCtD
Sevoflurane—CYP3A4—Pazopanib—kidney cancer	0.0176	0.0669	CbGbCtD
Sevoflurane—CYP3A4—Erlotinib—kidney cancer	0.0126	0.0478	CbGbCtD
Sevoflurane—CYP3A4—Paclitaxel—kidney cancer	0.0115	0.0437	CbGbCtD
Sevoflurane—CYP3A4—Sorafenib—kidney cancer	0.0102	0.0388	CbGbCtD
Sevoflurane—CYP3A4—Vinblastine—kidney cancer	0.0101	0.0383	CbGbCtD
Sevoflurane—CYP3A4—Vincristine—kidney cancer	0.00993	0.0377	CbGbCtD
Sevoflurane—CYP3A4—Sunitinib—kidney cancer	0.00829	0.0315	CbGbCtD
Sevoflurane—CYP3A4—Doxorubicin—kidney cancer	0.00621	0.0236	CbGbCtD
Sevoflurane—KCNK10—renal system—kidney cancer	0.00477	0.0634	CbGeAlD
Sevoflurane—KCNK10—kidney—kidney cancer	0.00461	0.0613	CbGeAlD
Sevoflurane—KCNK3—renal system—kidney cancer	0.0043	0.0572	CbGeAlD
Sevoflurane—KCNK3—kidney—kidney cancer	0.00416	0.0553	CbGeAlD
Sevoflurane—CYP2E1—urine—kidney cancer	0.00391	0.0521	CbGeAlD
Sevoflurane—CYP3A4—urine—kidney cancer	0.00315	0.0419	CbGeAlD
Sevoflurane—ND1—renal system—kidney cancer	0.00298	0.0397	CbGeAlD
Sevoflurane—ND1—kidney—kidney cancer	0.00288	0.0384	CbGeAlD
Sevoflurane—ND1—gonad—kidney cancer	0.00267	0.0356	CbGeAlD
Sevoflurane—ATP5D—nephron tubule—kidney cancer	0.00264	0.0352	CbGeAlD
Sevoflurane—ATP2C1—nephron tubule—kidney cancer	0.00261	0.0347	CbGeAlD
Sevoflurane—ATP5D—renal system—kidney cancer	0.0024	0.032	CbGeAlD
Sevoflurane—ATP2C1—renal system—kidney cancer	0.00237	0.0316	CbGeAlD
Sevoflurane—ATP5D—kidney—kidney cancer	0.00232	0.0309	CbGeAlD
Sevoflurane—ATP2C1—kidney—kidney cancer	0.00229	0.0305	CbGeAlD
Sevoflurane—ATP5D—cortex of kidney—kidney cancer	0.00226	0.0301	CbGeAlD
Sevoflurane—ATP2C1—cortex of kidney—kidney cancer	0.00223	0.0297	CbGeAlD
Sevoflurane—ATP5D—gonad—kidney cancer	0.00216	0.0287	CbGeAlD
Sevoflurane—ATP5D—cardiac atrium—kidney cancer	0.00215	0.0286	CbGeAlD
Sevoflurane—ATP2C1—gonad—kidney cancer	0.00213	0.0283	CbGeAlD
Sevoflurane—ATP2C1—cardiac atrium—kidney cancer	0.00212	0.0283	CbGeAlD
Sevoflurane—GABRA2—cortex of kidney—kidney cancer	0.00169	0.0224	CbGeAlD
Sevoflurane—GABRE—cardiac atrium—kidney cancer	0.00159	0.0212	CbGeAlD
Sevoflurane—GABRB3—gonad—kidney cancer	0.00135	0.018	CbGeAlD
Sevoflurane—CYP2B6—nephron tubule—kidney cancer	0.00112	0.0149	CbGeAlD
Sevoflurane—CYP2E1—nephron tubule—kidney cancer	0.00105	0.014	CbGeAlD
Sevoflurane—CYP2B6—renal system—kidney cancer	0.00102	0.0136	CbGeAlD
Sevoflurane—CYP2B6—kidney—kidney cancer	0.000986	0.0131	CbGeAlD
Sevoflurane—CYP2E1—renal system—kidney cancer	0.000958	0.0127	CbGeAlD
Sevoflurane—CYP2E1—kidney—kidney cancer	0.000926	0.0123	CbGeAlD
Sevoflurane—CYP2B6—gonad—kidney cancer	0.000915	0.0122	CbGeAlD
Sevoflurane—CYP2E1—cortex of kidney—kidney cancer	0.000902	0.012	CbGeAlD
Sevoflurane—CYP3A4—renal system—kidney cancer	0.00077	0.0102	CbGeAlD
Sevoflurane—CYP3A4—kidney—kidney cancer	0.000745	0.00991	CbGeAlD
Sevoflurane—Pain—Sunitinib—kidney cancer	0.000477	0.000982	CcSEcCtD
Sevoflurane—Immune system disorder—Paclitaxel—kidney cancer	0.000476	0.000981	CcSEcCtD
Sevoflurane—Mediastinal disorder—Paclitaxel—kidney cancer	0.000475	0.000979	CcSEcCtD
Sevoflurane—Renal failure—Capecitabine—kidney cancer	0.000474	0.000976	CcSEcCtD
Sevoflurane—Hypertension—Gemcitabine—kidney cancer	0.000473	0.000975	CcSEcCtD
Sevoflurane—Chills—Paclitaxel—kidney cancer	0.000473	0.000974	CcSEcCtD
Sevoflurane—Pruritus—Everolimus—kidney cancer	0.000472	0.000973	CcSEcCtD
Sevoflurane—Oedema—Vincristine—kidney cancer	0.000472	0.000971	CcSEcCtD
Sevoflurane—Anaphylactic shock—Vincristine—kidney cancer	0.000472	0.000971	CcSEcCtD
Sevoflurane—Arrhythmia—Paclitaxel—kidney cancer	0.000471	0.00097	CcSEcCtD
Sevoflurane—Jaundice—Capecitabine—kidney cancer	0.00047	0.000968	CcSEcCtD
Sevoflurane—Conjunctivitis—Capecitabine—kidney cancer	0.000468	0.000965	CcSEcCtD
Sevoflurane—Chest pain—Gemcitabine—kidney cancer	0.000467	0.000961	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000463	0.000955	CcSEcCtD
Sevoflurane—Nervous system disorder—Vincristine—kidney cancer	0.000462	0.000953	CcSEcCtD
Sevoflurane—Asthenia—Erlotinib—kidney cancer	0.000462	0.000952	CcSEcCtD
Sevoflurane—Mental disorder—Paclitaxel—kidney cancer	0.000462	0.000951	CcSEcCtD
Sevoflurane—Thrombocytopenia—Vincristine—kidney cancer	0.000462	0.000951	CcSEcCtD
Sevoflurane—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000461	0.00095	CcSEcCtD
Sevoflurane—Urticaria—Sorafenib—kidney cancer	0.00046	0.000948	CcSEcCtD
Sevoflurane—Malnutrition—Paclitaxel—kidney cancer	0.000459	0.000945	CcSEcCtD
Sevoflurane—Body temperature increased—Sorafenib—kidney cancer	0.000458	0.000944	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Capecitabine—kidney cancer	0.000456	0.000939	CcSEcCtD
Sevoflurane—Pruritus—Erlotinib—kidney cancer	0.000456	0.000939	CcSEcCtD
Sevoflurane—Pain—Dactinomycin—kidney cancer	0.000451	0.00093	CcSEcCtD
Sevoflurane—Tension—Paclitaxel—kidney cancer	0.00045	0.000928	CcSEcCtD
Sevoflurane—Dysgeusia—Paclitaxel—kidney cancer	0.000449	0.000926	CcSEcCtD
Sevoflurane—Hepatic failure—Doxorubicin—kidney cancer	0.000449	0.000924	CcSEcCtD
Sevoflurane—Anaphylactic shock—Gemcitabine—kidney cancer	0.000447	0.000922	CcSEcCtD
Sevoflurane—Oedema—Gemcitabine—kidney cancer	0.000447	0.000922	CcSEcCtD
Sevoflurane—Nervousness—Paclitaxel—kidney cancer	0.000446	0.000918	CcSEcCtD
Sevoflurane—Dizziness—Vinblastine—kidney cancer	0.000443	0.000913	CcSEcCtD
Sevoflurane—Dizziness—Everolimus—kidney cancer	0.000441	0.000909	CcSEcCtD
Sevoflurane—Body temperature increased—Sunitinib—kidney cancer	0.000441	0.000908	CcSEcCtD
Sevoflurane—Hypotension—Vincristine—kidney cancer	0.000441	0.000908	CcSEcCtD
Sevoflurane—Bradycardia—Capecitabine—kidney cancer	0.00044	0.000907	CcSEcCtD
Sevoflurane—Nervous system disorder—Gemcitabine—kidney cancer	0.000439	0.000904	CcSEcCtD
Sevoflurane—Thrombocytopenia—Gemcitabine—kidney cancer	0.000438	0.000902	CcSEcCtD
Sevoflurane—Renal failure acute—Doxorubicin—kidney cancer	0.000437	0.000899	CcSEcCtD
Sevoflurane—Feeling abnormal—Dactinomycin—kidney cancer	0.000435	0.000896	CcSEcCtD
Sevoflurane—Haemoglobin—Capecitabine—kidney cancer	0.000435	0.000896	CcSEcCtD
Sevoflurane—Skin disorder—Gemcitabine—kidney cancer	0.000435	0.000895	CcSEcCtD
Sevoflurane—Haemorrhage—Capecitabine—kidney cancer	0.000433	0.000891	CcSEcCtD
Sevoflurane—Hepatitis—Capecitabine—kidney cancer	0.000433	0.000891	CcSEcCtD
Sevoflurane—Pharyngitis—Capecitabine—kidney cancer	0.000429	0.000885	CcSEcCtD
Sevoflurane—Urinary tract disorder—Capecitabine—kidney cancer	0.000427	0.00088	CcSEcCtD
Sevoflurane—Hypersensitivity—Sorafenib—kidney cancer	0.000427	0.000879	CcSEcCtD
Sevoflurane—Insomnia—Vincristine—kidney cancer	0.000427	0.000879	CcSEcCtD
Sevoflurane—Vomiting—Vinblastine—kidney cancer	0.000426	0.000878	CcSEcCtD
Sevoflurane—Dizziness—Erlotinib—kidney cancer	0.000426	0.000877	CcSEcCtD
Sevoflurane—Vomiting—Everolimus—kidney cancer	0.000424	0.000874	CcSEcCtD
Sevoflurane—Urethral disorder—Capecitabine—kidney cancer	0.000424	0.000874	CcSEcCtD
Sevoflurane—Agitation—Paclitaxel—kidney cancer	0.000422	0.000869	CcSEcCtD
Sevoflurane—Rash—Everolimus—kidney cancer	0.000421	0.000867	CcSEcCtD
Sevoflurane—Dermatitis—Everolimus—kidney cancer	0.00042	0.000866	CcSEcCtD
Sevoflurane—Headache—Vinblastine—kidney cancer	0.00042	0.000865	CcSEcCtD
Sevoflurane—Headache—Everolimus—kidney cancer	0.000418	0.000861	CcSEcCtD
Sevoflurane—Hypotension—Gemcitabine—kidney cancer	0.000418	0.000861	CcSEcCtD
Sevoflurane—Body temperature increased—Dactinomycin—kidney cancer	0.000417	0.00086	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000417	0.000858	CcSEcCtD
Sevoflurane—Asthenia—Sorafenib—kidney cancer	0.000416	0.000856	CcSEcCtD
Sevoflurane—Syncope—Paclitaxel—kidney cancer	0.000412	0.000848	CcSEcCtD
Sevoflurane—Hypersensitivity—Sunitinib—kidney cancer	0.000411	0.000846	CcSEcCtD
Sevoflurane—Pruritus—Sorafenib—kidney cancer	0.00041	0.000844	CcSEcCtD
Sevoflurane—Vomiting—Erlotinib—kidney cancer	0.000409	0.000844	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Vincristine—kidney cancer	0.000407	0.000839	CcSEcCtD
Sevoflurane—Rash—Erlotinib—kidney cancer	0.000406	0.000837	CcSEcCtD
Sevoflurane—Dermatitis—Erlotinib—kidney cancer	0.000406	0.000836	CcSEcCtD
Sevoflurane—Insomnia—Gemcitabine—kidney cancer	0.000405	0.000834	CcSEcCtD
Sevoflurane—Headache—Erlotinib—kidney cancer	0.000403	0.000831	CcSEcCtD
Sevoflurane—Loss of consciousness—Paclitaxel—kidney cancer	0.000403	0.000831	CcSEcCtD
Sevoflurane—Pain—Vincristine—kidney cancer	0.000403	0.000831	CcSEcCtD
Sevoflurane—Cardiac disorder—Capecitabine—kidney cancer	0.000402	0.000827	CcSEcCtD
Sevoflurane—Cough—Paclitaxel—kidney cancer	0.0004	0.000825	CcSEcCtD
Sevoflurane—Asthenia—Sunitinib—kidney cancer	0.0004	0.000824	CcSEcCtD
Sevoflurane—Dyspnoea—Gemcitabine—kidney cancer	0.000399	0.000822	CcSEcCtD
Sevoflurane—Nausea—Vinblastine—kidney cancer	0.000398	0.00082	CcSEcCtD
Sevoflurane—Somnolence—Gemcitabine—kidney cancer	0.000398	0.000819	CcSEcCtD
Sevoflurane—Convulsion—Paclitaxel—kidney cancer	0.000398	0.000819	CcSEcCtD
Sevoflurane—Nausea—Everolimus—kidney cancer	0.000396	0.000817	CcSEcCtD
Sevoflurane—Hypertension—Paclitaxel—kidney cancer	0.000396	0.000816	CcSEcCtD
Sevoflurane—Pruritus—Sunitinib—kidney cancer	0.000394	0.000813	CcSEcCtD
Sevoflurane—Angiopathy—Capecitabine—kidney cancer	0.000393	0.000809	CcSEcCtD
Sevoflurane—Immune system disorder—Capecitabine—kidney cancer	0.000391	0.000805	CcSEcCtD
Sevoflurane—Chest pain—Paclitaxel—kidney cancer	0.000391	0.000805	CcSEcCtD
Sevoflurane—Mediastinal disorder—Capecitabine—kidney cancer	0.00039	0.000803	CcSEcCtD
Sevoflurane—Hypersensitivity—Dactinomycin—kidney cancer	0.000389	0.000801	CcSEcCtD
Sevoflurane—Chills—Capecitabine—kidney cancer	0.000388	0.0008	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000388	0.000799	CcSEcCtD
Sevoflurane—Arrhythmia—Capecitabine—kidney cancer	0.000386	0.000796	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000386	0.000796	CcSEcCtD
Sevoflurane—Cardiac arrest—Doxorubicin—kidney cancer	0.000383	0.00079	CcSEcCtD
Sevoflurane—Dizziness—Sorafenib—kidney cancer	0.000383	0.000789	CcSEcCtD
Sevoflurane—Pain—Gemcitabine—kidney cancer	0.000383	0.000788	CcSEcCtD
Sevoflurane—Nausea—Erlotinib—kidney cancer	0.000383	0.000788	CcSEcCtD
Sevoflurane—Dry mouth—Paclitaxel—kidney cancer	0.000382	0.000787	CcSEcCtD
Sevoflurane—Mental disorder—Capecitabine—kidney cancer	0.000379	0.000781	CcSEcCtD
Sevoflurane—Asthenia—Dactinomycin—kidney cancer	0.000379	0.00078	CcSEcCtD
Sevoflurane—Confusional state—Paclitaxel—kidney cancer	0.000378	0.000778	CcSEcCtD
Sevoflurane—Malnutrition—Capecitabine—kidney cancer	0.000377	0.000776	CcSEcCtD
Sevoflurane—Anaphylactic shock—Paclitaxel—kidney cancer	0.000375	0.000772	CcSEcCtD
Sevoflurane—Oedema—Paclitaxel—kidney cancer	0.000375	0.000772	CcSEcCtD
Sevoflurane—Body temperature increased—Vincristine—kidney cancer	0.000373	0.000768	CcSEcCtD
Sevoflurane—Liver function test abnormal—Doxorubicin—kidney cancer	0.000372	0.000767	CcSEcCtD
Sevoflurane—Dysgeusia—Capecitabine—kidney cancer	0.000369	0.00076	CcSEcCtD
Sevoflurane—Dizziness—Sunitinib—kidney cancer	0.000369	0.000759	CcSEcCtD
Sevoflurane—Feeling abnormal—Gemcitabine—kidney cancer	0.000369	0.000759	CcSEcCtD
Sevoflurane—Shock—Paclitaxel—kidney cancer	0.000368	0.000759	CcSEcCtD
Sevoflurane—Vomiting—Sorafenib—kidney cancer	0.000368	0.000759	CcSEcCtD
Sevoflurane—Nervous system disorder—Paclitaxel—kidney cancer	0.000367	0.000757	CcSEcCtD
Sevoflurane—Thrombocytopenia—Paclitaxel—kidney cancer	0.000367	0.000755	CcSEcCtD
Sevoflurane—Tachycardia—Paclitaxel—kidney cancer	0.000366	0.000753	CcSEcCtD
Sevoflurane—Rash—Sorafenib—kidney cancer	0.000365	0.000753	CcSEcCtD
Sevoflurane—Dermatitis—Sorafenib—kidney cancer	0.000365	0.000752	CcSEcCtD
Sevoflurane—Skin disorder—Paclitaxel—kidney cancer	0.000364	0.000749	CcSEcCtD
Sevoflurane—Headache—Sorafenib—kidney cancer	0.000363	0.000748	CcSEcCtD
Sevoflurane—Vomiting—Sunitinib—kidney cancer	0.000354	0.00073	CcSEcCtD
Sevoflurane—Body temperature increased—Gemcitabine—kidney cancer	0.000354	0.000729	CcSEcCtD
Sevoflurane—Rash—Sunitinib—kidney cancer	0.000352	0.000724	CcSEcCtD
Sevoflurane—Dermatitis—Sunitinib—kidney cancer	0.000351	0.000723	CcSEcCtD
Sevoflurane—Hypotension—Paclitaxel—kidney cancer	0.00035	0.000721	CcSEcCtD
Sevoflurane—Headache—Sunitinib—kidney cancer	0.000349	0.00072	CcSEcCtD
Sevoflurane—Hypersensitivity—Vincristine—kidney cancer	0.000347	0.000716	CcSEcCtD
Sevoflurane—Nausea—Sorafenib—kidney cancer	0.000344	0.000709	CcSEcCtD
Sevoflurane—Pancreatitis—Doxorubicin—kidney cancer	0.000342	0.000704	CcSEcCtD
Sevoflurane—Insomnia—Paclitaxel—kidney cancer	0.000339	0.000698	CcSEcCtD
Sevoflurane—Asthenia—Vincristine—kidney cancer	0.000338	0.000697	CcSEcCtD
Sevoflurane—Syncope—Capecitabine—kidney cancer	0.000338	0.000696	CcSEcCtD
Sevoflurane—Vomiting—Dactinomycin—kidney cancer	0.000336	0.000691	CcSEcCtD
Sevoflurane—Dyspnoea—Paclitaxel—kidney cancer	0.000334	0.000688	CcSEcCtD
Sevoflurane—Somnolence—Paclitaxel—kidney cancer	0.000333	0.000686	CcSEcCtD
Sevoflurane—Rash—Dactinomycin—kidney cancer	0.000333	0.000686	CcSEcCtD
Sevoflurane—Nausea—Sunitinib—kidney cancer	0.000331	0.000682	CcSEcCtD
Sevoflurane—Loss of consciousness—Capecitabine—kidney cancer	0.000331	0.000682	CcSEcCtD
Sevoflurane—Cough—Capecitabine—kidney cancer	0.000329	0.000677	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—kidney cancer	0.000326	0.000671	CcSEcCtD
Sevoflurane—Hypertension—Capecitabine—kidney cancer	0.000325	0.00067	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000323	0.000666	CcSEcCtD
Sevoflurane—Asthenia—Gemcitabine—kidney cancer	0.000321	0.000661	CcSEcCtD
Sevoflurane—Chest pain—Capecitabine—kidney cancer	0.000321	0.000661	CcSEcCtD
Sevoflurane—Pain—Paclitaxel—kidney cancer	0.00032	0.00066	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000318	0.000656	CcSEcCtD
Sevoflurane—Pruritus—Gemcitabine—kidney cancer	0.000317	0.000652	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—kidney cancer	0.000314	0.000647	CcSEcCtD
Sevoflurane—Dry mouth—Capecitabine—kidney cancer	0.000314	0.000646	CcSEcCtD
Sevoflurane—Nausea—Dactinomycin—kidney cancer	0.000314	0.000646	CcSEcCtD
Sevoflurane—Dizziness—Vincristine—kidney cancer	0.000312	0.000642	CcSEcCtD
Sevoflurane—Confusional state—Capecitabine—kidney cancer	0.00031	0.000638	CcSEcCtD
Sevoflurane—Feeling abnormal—Paclitaxel—kidney cancer	0.000309	0.000636	CcSEcCtD
Sevoflurane—Oedema—Capecitabine—kidney cancer	0.000307	0.000633	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—kidney cancer	0.000305	0.000629	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—kidney cancer	0.000303	0.000624	CcSEcCtD
Sevoflurane—Shock—Capecitabine—kidney cancer	0.000302	0.000623	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—kidney cancer	0.000302	0.000622	CcSEcCtD
Sevoflurane—Nervous system disorder—Capecitabine—kidney cancer	0.000301	0.000621	CcSEcCtD
Sevoflurane—Thrombocytopenia—Capecitabine—kidney cancer	0.000301	0.00062	CcSEcCtD
Sevoflurane—Tachycardia—Capecitabine—kidney cancer	0.0003	0.000618	CcSEcCtD
Sevoflurane—Vomiting—Vincristine—kidney cancer	0.0003	0.000618	CcSEcCtD
Sevoflurane—Skin disorder—Capecitabine—kidney cancer	0.000299	0.000615	CcSEcCtD
Sevoflurane—Urticaria—Paclitaxel—kidney cancer	0.000298	0.000613	CcSEcCtD
Sevoflurane—Rash—Vincristine—kidney cancer	0.000297	0.000613	CcSEcCtD
Sevoflurane—Dermatitis—Vincristine—kidney cancer	0.000297	0.000612	CcSEcCtD
Sevoflurane—Body temperature increased—Paclitaxel—kidney cancer	0.000296	0.00061	CcSEcCtD
Sevoflurane—Headache—Vincristine—kidney cancer	0.000295	0.000609	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000294	0.000605	CcSEcCtD
Sevoflurane—Hypotension—Capecitabine—kidney cancer	0.000287	0.000592	CcSEcCtD
Sevoflurane—Vomiting—Gemcitabine—kidney cancer	0.000284	0.000586	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—kidney cancer	0.000284	0.000585	CcSEcCtD
Sevoflurane—Rash—Gemcitabine—kidney cancer	0.000282	0.000581	CcSEcCtD
Sevoflurane—Dermatitis—Gemcitabine—kidney cancer	0.000282	0.000581	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—kidney cancer	0.00028	0.000577	CcSEcCtD
Sevoflurane—Headache—Gemcitabine—kidney cancer	0.00028	0.000577	CcSEcCtD
Sevoflurane—Nausea—Vincristine—kidney cancer	0.00028	0.000577	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—kidney cancer	0.000279	0.000574	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—kidney cancer	0.000279	0.000574	CcSEcCtD
Sevoflurane—Insomnia—Capecitabine—kidney cancer	0.000278	0.000573	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—kidney cancer	0.000277	0.00057	CcSEcCtD
Sevoflurane—Hypersensitivity—Paclitaxel—kidney cancer	0.000276	0.000568	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—kidney cancer	0.000275	0.000567	CcSEcCtD
Sevoflurane—Dyspnoea—Capecitabine—kidney cancer	0.000274	0.000565	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—kidney cancer	0.000273	0.000563	CcSEcCtD
Sevoflurane—Asthenia—Paclitaxel—kidney cancer	0.000269	0.000554	CcSEcCtD
Sevoflurane—Nausea—Gemcitabine—kidney cancer	0.000266	0.000547	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000265	0.000547	CcSEcCtD
Sevoflurane—Pruritus—Paclitaxel—kidney cancer	0.000265	0.000546	CcSEcCtD
Sevoflurane—Pain—Capecitabine—kidney cancer	0.000263	0.000541	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—kidney cancer	0.000259	0.000533	CcSEcCtD
Sevoflurane—Feeling abnormal—Capecitabine—kidney cancer	0.000253	0.000522	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—kidney cancer	0.000253	0.000521	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—kidney cancer	0.000252	0.000519	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—kidney cancer	0.000251	0.000518	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—kidney cancer	0.00025	0.000515	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—kidney cancer	0.000249	0.000513	CcSEcCtD
Sevoflurane—Dizziness—Paclitaxel—kidney cancer	0.000248	0.00051	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—kidney cancer	0.000244	0.000503	CcSEcCtD
Sevoflurane—Urticaria—Capecitabine—kidney cancer	0.000244	0.000503	CcSEcCtD
Sevoflurane—Body temperature increased—Capecitabine—kidney cancer	0.000243	0.000501	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—kidney cancer	0.000243	0.0005	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—kidney cancer	0.000238	0.000491	CcSEcCtD
Sevoflurane—Vomiting—Paclitaxel—kidney cancer	0.000238	0.000491	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—kidney cancer	0.000238	0.00049	CcSEcCtD
Sevoflurane—Rash—Paclitaxel—kidney cancer	0.000236	0.000486	CcSEcCtD
Sevoflurane—Dermatitis—Paclitaxel—kidney cancer	0.000236	0.000486	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—kidney cancer	0.000236	0.000486	CcSEcCtD
Sevoflurane—Headache—Paclitaxel—kidney cancer	0.000235	0.000483	CcSEcCtD
Sevoflurane—Hypersensitivity—Capecitabine—kidney cancer	0.000226	0.000467	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—kidney cancer	0.000223	0.00046	CcSEcCtD
Sevoflurane—Nausea—Paclitaxel—kidney cancer	0.000222	0.000458	CcSEcCtD
Sevoflurane—Asthenia—Capecitabine—kidney cancer	0.000221	0.000454	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—kidney cancer	0.000218	0.000448	CcSEcCtD
Sevoflurane—Pruritus—Capecitabine—kidney cancer	0.000217	0.000448	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—kidney cancer	0.000213	0.00044	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—kidney cancer	0.000212	0.000436	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—kidney cancer	0.00021	0.000433	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—kidney cancer	0.00021	0.000432	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—kidney cancer	0.000207	0.000426	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000205	0.000423	CcSEcCtD
Sevoflurane—Dizziness—Capecitabine—kidney cancer	0.000203	0.000419	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—kidney cancer	0.000202	0.000416	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—kidney cancer	0.0002	0.000412	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—kidney cancer	0.000198	0.000408	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—kidney cancer	0.000198	0.000408	CcSEcCtD
Sevoflurane—Vomiting—Capecitabine—kidney cancer	0.000195	0.000403	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—kidney cancer	0.000195	0.000402	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—kidney cancer	0.000194	0.0004	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—kidney cancer	0.000194	0.0004	CcSEcCtD
Sevoflurane—Rash—Capecitabine—kidney cancer	0.000194	0.000399	CcSEcCtD
Sevoflurane—Dermatitis—Capecitabine—kidney cancer	0.000194	0.000399	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—kidney cancer	0.000193	0.000398	CcSEcCtD
Sevoflurane—Headache—Capecitabine—kidney cancer	0.000193	0.000397	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—kidney cancer	0.000192	0.000396	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—kidney cancer	0.000185	0.000381	CcSEcCtD
Sevoflurane—Nausea—Capecitabine—kidney cancer	0.000183	0.000376	CcSEcCtD
Sevoflurane—Insomnia—Doxorubicin—kidney cancer	0.000179	0.000369	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—kidney cancer	0.000177	0.000364	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—kidney cancer	0.000176	0.000363	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000171	0.000352	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—kidney cancer	0.000169	0.000349	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—kidney cancer	0.000163	0.000336	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—kidney cancer	0.000157	0.000324	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—kidney cancer	0.000157	0.000323	CcSEcCtD
Sevoflurane—Hypersensitivity—Doxorubicin—kidney cancer	0.000146	0.000301	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—kidney cancer	0.000142	0.000293	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—kidney cancer	0.00014	0.000289	CcSEcCtD
Sevoflurane—Dizziness—Doxorubicin—kidney cancer	0.000131	0.00027	CcSEcCtD
Sevoflurane—Vomiting—Doxorubicin—kidney cancer	0.000126	0.00026	CcSEcCtD
Sevoflurane—Rash—Doxorubicin—kidney cancer	0.000125	0.000257	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—kidney cancer	0.000125	0.000257	CcSEcCtD
Sevoflurane—Headache—Doxorubicin—kidney cancer	0.000124	0.000256	CcSEcCtD
Sevoflurane—Nausea—Doxorubicin—kidney cancer	0.000118	0.000242	CcSEcCtD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.59e-05	0.000317	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—PTGS1—kidney cancer	5.56e-05	0.000316	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CCBL1—kidney cancer	5.54e-05	0.000315	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—FH—kidney cancer	5.54e-05	0.000314	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—APRT—kidney cancer	5.54e-05	0.000314	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—RAF1—kidney cancer	5.53e-05	0.000314	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.49e-05	0.000312	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—GRB7—kidney cancer	5.47e-05	0.00031	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	5.46e-05	0.00031	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CCBL1—kidney cancer	5.43e-05	0.000308	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.42e-05	0.000308	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.39e-05	0.000306	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.36e-05	0.000304	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.26e-05	0.000299	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.26e-05	0.000299	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GPC3—kidney cancer	5.2e-05	0.000296	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.17e-05	0.000294	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—ITPR2—kidney cancer	5.08e-05	0.000289	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.08e-05	0.000288	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CA2—kidney cancer	5.06e-05	0.000288	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—kidney cancer	5.05e-05	0.000287	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.05e-05	0.000287	CbGpPWpGaD
Sevoflurane—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.03e-05	0.000285	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.98e-05	0.000283	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PDHB—kidney cancer	4.96e-05	0.000282	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	4.95e-05	0.000281	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ALAD—kidney cancer	4.93e-05	0.00028	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—MAPK1—kidney cancer	4.93e-05	0.00028	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—MAPK1—kidney cancer	4.86e-05	0.000276	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—RAF1—kidney cancer	4.84e-05	0.000275	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ST3GAL2—kidney cancer	4.82e-05	0.000274	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GLIPR1—kidney cancer	4.8e-05	0.000273	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPAT—kidney cancer	4.8e-05	0.000273	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ALDH1A1—kidney cancer	4.71e-05	0.000267	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPAT—kidney cancer	4.71e-05	0.000267	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GLIPR1—kidney cancer	4.71e-05	0.000267	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—RAF1—kidney cancer	4.69e-05	0.000267	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CCBL1—kidney cancer	4.66e-05	0.000265	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—POMC—kidney cancer	4.64e-05	0.000264	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—POMC—kidney cancer	4.64e-05	0.000264	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.6e-05	0.000261	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—MAPK1—kidney cancer	4.6e-05	0.000261	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—MAPK1—kidney cancer	4.54e-05	0.000258	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PGK1—kidney cancer	4.51e-05	0.000256	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SLC5A3—kidney cancer	4.51e-05	0.000256	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—APRT—kidney cancer	4.47e-05	0.000254	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—FH—kidney cancer	4.47e-05	0.000254	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—LDHB—kidney cancer	4.43e-05	0.000251	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—APRT—kidney cancer	4.37e-05	0.000248	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—FH—kidney cancer	4.37e-05	0.000248	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	4.33e-05	0.000246	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.22e-05	0.00024	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GPC3—kidney cancer	4.2e-05	0.000239	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—MAPK1—kidney cancer	4.15e-05	0.000236	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GPC3—kidney cancer	4.11e-05	0.000234	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4.11e-05	0.000233	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CA2—kidney cancer	4.08e-05	0.000232	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.05e-05	0.00023	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPAT—kidney cancer	4.04e-05	0.00023	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GLIPR1—kidney cancer	4.04e-05	0.00023	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—MAPK1—kidney cancer	4.03e-05	0.000229	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CA2—kidney cancer	4e-05	0.000227	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.99e-05	0.000227	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ALAD—kidney cancer	3.98e-05	0.000226	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—MAPK1—kidney cancer	3.96e-05	0.000225	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.95e-05	0.000225	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ALAD—kidney cancer	3.9e-05	0.000221	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—MAPK1—kidney cancer	3.89e-05	0.000221	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ST3GAL2—kidney cancer	3.89e-05	0.000221	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—MAPK1—kidney cancer	3.87e-05	0.00022	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.87e-05	0.00022	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CA9—kidney cancer	3.84e-05	0.000218	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.81e-05	0.000216	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ST3GAL2—kidney cancer	3.81e-05	0.000216	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ALDH1A1—kidney cancer	3.8e-05	0.000216	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—MAPK1—kidney cancer	3.8e-05	0.000216	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.78e-05	0.000215	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—APRT—kidney cancer	3.76e-05	0.000214	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—FH—kidney cancer	3.76e-05	0.000214	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNA1—kidney cancer	3.73e-05	0.000212	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.73e-05	0.000212	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ALDH1A1—kidney cancer	3.72e-05	0.000211	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTGS2—kidney cancer	3.7e-05	0.00021	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTGS2—kidney cancer	3.7e-05	0.00021	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.67e-05	0.000209	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PGK1—kidney cancer	3.64e-05	0.000207	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC5A3—kidney cancer	3.64e-05	0.000207	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	3.6e-05	0.000205	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.58e-05	0.000203	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—LDHB—kidney cancer	3.57e-05	0.000203	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PGK1—kidney cancer	3.57e-05	0.000203	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC5A3—kidney cancer	3.57e-05	0.000203	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	3.56e-05	0.000202	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GPC3—kidney cancer	3.53e-05	0.000201	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.53e-05	0.000201	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—LDHB—kidney cancer	3.5e-05	0.000199	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNA2—kidney cancer	3.47e-05	0.000197	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.45e-05	0.000196	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CA2—kidney cancer	3.44e-05	0.000195	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ALAD—kidney cancer	3.35e-05	0.00019	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	3.34e-05	0.00019	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.33e-05	0.000189	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—MAPK1—kidney cancer	3.32e-05	0.000188	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ST3GAL2—kidney cancer	3.27e-05	0.000186	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CRABP1—kidney cancer	3.26e-05	0.000185	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.25e-05	0.000185	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTEN—kidney cancer	3.23e-05	0.000183	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTEN—kidney cancer	3.23e-05	0.000183	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ALDH1A1—kidney cancer	3.2e-05	0.000182	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	3.16e-05	0.00018	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ACY1—kidney cancer	3.15e-05	0.000179	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IGF2—kidney cancer	3.13e-05	0.000178	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.1e-05	0.000176	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CA9—kidney cancer	3.1e-05	0.000176	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PGK1—kidney cancer	3.06e-05	0.000174	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC5A3—kidney cancer	3.06e-05	0.000174	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.05e-05	0.000173	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ITPR2—kidney cancer	3.03e-05	0.000172	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CA9—kidney cancer	3.03e-05	0.000172	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.03e-05	0.000172	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—LDHB—kidney cancer	3.01e-05	0.000171	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.99e-05	0.00017	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.98e-05	0.000169	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTT1—kidney cancer	2.77e-05	0.000157	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ACHE—kidney cancer	2.77e-05	0.000157	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PDHB—kidney cancer	2.68e-05	0.000152	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—POMC—kidney cancer	2.67e-05	0.000152	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CRABP1—kidney cancer	2.63e-05	0.00015	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.63e-05	0.000149	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SCARB1—kidney cancer	2.62e-05	0.000149	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CA9—kidney cancer	2.61e-05	0.000148	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.6e-05	0.000148	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS1—kidney cancer	2.59e-05	0.000147	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CRABP1—kidney cancer	2.58e-05	0.000146	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.55e-05	0.000145	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.54e-05	0.000144	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PSMD7—kidney cancer	2.54e-05	0.000144	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CCBL1—kidney cancer	2.52e-05	0.000143	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ITPR2—kidney cancer	2.45e-05	0.000139	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—BCHE—kidney cancer	2.41e-05	0.000137	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.41e-05	0.000137	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ITPR2—kidney cancer	2.4e-05	0.000136	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SLC5A5—kidney cancer	2.38e-05	0.000135	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SLC2A1—kidney cancer	2.3e-05	0.000131	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.29e-05	0.00013	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CA—kidney cancer	2.28e-05	0.000129	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CA—kidney cancer	2.28e-05	0.000129	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ACHE—kidney cancer	2.23e-05	0.000127	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTT1—kidney cancer	2.23e-05	0.000127	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CRABP1—kidney cancer	2.22e-05	0.000126	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTT1—kidney cancer	2.19e-05	0.000124	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ACHE—kidney cancer	2.19e-05	0.000124	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPAT—kidney cancer	2.18e-05	0.000124	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.18e-05	0.000124	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SCARB1—kidney cancer	2.11e-05	0.00012	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS1—kidney cancer	2.09e-05	0.000119	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SCARB1—kidney cancer	2.07e-05	0.000118	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ITPR2—kidney cancer	2.06e-05	0.000117	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PSMD7—kidney cancer	2.05e-05	0.000116	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS1—kidney cancer	2.05e-05	0.000116	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—FH—kidney cancer	2.03e-05	0.000115	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—APRT—kidney cancer	2.03e-05	0.000115	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PSMD7—kidney cancer	2.01e-05	0.000114	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.99e-05	0.000113	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—BCHE—kidney cancer	1.94e-05	0.00011	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.92e-05	0.000109	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTP1—kidney cancer	1.92e-05	0.000109	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GPC3—kidney cancer	1.91e-05	0.000108	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—BCHE—kidney cancer	1.9e-05	0.000108	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.9e-05	0.000108	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.88e-05	0.000107	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ACHE—kidney cancer	1.88e-05	0.000107	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTT1—kidney cancer	1.88e-05	0.000107	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CA2—kidney cancer	1.86e-05	0.000105	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.85e-05	0.000105	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.82e-05	0.000103	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ABCB1—kidney cancer	1.81e-05	0.000103	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ALAD—kidney cancer	1.81e-05	0.000103	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SCARB1—kidney cancer	1.78e-05	0.000101	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.77e-05	0.0001	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTM1—kidney cancer	1.76e-05	0.0001	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS1—kidney cancer	1.76e-05	0.0001	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PSMD7—kidney cancer	1.73e-05	9.81e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.73e-05	9.8e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—RAF1—kidney cancer	1.72e-05	9.77e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP1A1—kidney cancer	1.67e-05	9.49e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PGK1—kidney cancer	1.65e-05	9.4e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.65e-05	9.4e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—BCHE—kidney cancer	1.64e-05	9.3e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—LDHB—kidney cancer	1.62e-05	9.22e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC5A5—kidney cancer	1.62e-05	9.18e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC2A1—kidney cancer	1.56e-05	8.87e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTP1—kidney cancer	1.55e-05	8.79e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL2—kidney cancer	1.54e-05	8.76e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTP1—kidney cancer	1.52e-05	8.61e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.51e-05	8.6e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.49e-05	8.46e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCB1—kidney cancer	1.46e-05	8.32e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCB1—kidney cancer	1.43e-05	8.15e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTM1—kidney cancer	1.42e-05	8.07e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CA9—kidney cancer	1.41e-05	7.99e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTM1—kidney cancer	1.39e-05	7.91e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.35e-05	7.65e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.32e-05	7.5e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.32e-05	7.5e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—kidney cancer	1.31e-05	7.44e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTP1—kidney cancer	1.3e-05	7.4e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—POMC—kidney cancer	1.25e-05	7.07e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK3—kidney cancer	1.24e-05	7.04e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCB1—kidney cancer	1.23e-05	7e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTM1—kidney cancer	1.2e-05	6.8e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CRABP1—kidney cancer	1.2e-05	6.79e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAPK1—kidney cancer	1.18e-05	6.7e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP1A1—kidney cancer	1.13e-05	6.44e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KRAS—kidney cancer	1.11e-05	6.33e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ITPR2—kidney cancer	1.11e-05	6.32e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CA—kidney cancer	1.02e-05	5.81e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTT1—kidney cancer	1.01e-05	5.76e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ACHE—kidney cancer	1.01e-05	5.76e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—POMC—kidney cancer	1e-05	5.71e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS2—kidney cancer	9.93e-06	5.64e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—kidney cancer	9.9e-06	5.62e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—POMC—kidney cancer	9.84e-06	5.59e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SCARB1—kidney cancer	9.6e-06	5.45e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS1—kidney cancer	9.5e-06	5.4e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.32e-06	5.29e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PSMD7—kidney cancer	9.32e-06	5.29e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—BCHE—kidney cancer	8.83e-06	5.02e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.73e-06	4.96e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—kidney cancer	8.66e-06	4.92e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—POMC—kidney cancer	8.46e-06	4.8e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.43e-06	4.79e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS2—kidney cancer	8.01e-06	4.55e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS2—kidney cancer	7.85e-06	4.46e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTP1—kidney cancer	7.03e-06	3.99e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—kidney cancer	6.99e-06	3.97e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—kidney cancer	6.85e-06	3.89e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS2—kidney cancer	6.75e-06	3.83e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCB1—kidney cancer	6.65e-06	3.78e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTM1—kidney cancer	6.46e-06	3.67e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.12e-06	3.48e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CA—kidney cancer	6.11e-06	3.47e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—kidney cancer	5.88e-06	3.34e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CA—kidney cancer	4.93e-06	2.8e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CA—kidney cancer	4.83e-06	2.74e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—POMC—kidney cancer	4.57e-06	2.59e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CA—kidney cancer	4.15e-06	2.36e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS2—kidney cancer	3.64e-06	2.07e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—kidney cancer	3.18e-06	1.8e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.24e-06	1.27e-05	CbGpPWpGaD
